Advanced search
Publication Cover
Leukemia & Lymphoma Volume 62, 2021 - Issue 7
Submit an article Journal homepage
197
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Predicting severe toxicities with intensive induction chemotherapy for adult acute myeloid leukemia: analysis of SWOG Cancer Research Network trials S0106 and S1203

Anna Moseleya Public Health Sciences Division and SWOG Statistics and Data Management Center, Fred Hutchinson Cancer Research Center, Seattle, WA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-7514-7360View further author information
ORCID Icon,
Megan Othusa Public Health Sciences Division and SWOG Statistics and Data Management Center, Fred Hutchinson Cancer Research Center, Seattle, WA, USAView further author information
,
Guillermo Garcia-Manerob Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Frederick R. Appelbaumc Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA;d Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USAView further author information
,
Harry P. Erbae Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC, USAView further author information
&
Roland B. Walterc Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA;f Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA;g Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA;h Department of Epidemiology, University of Washington, Seattle, WA, USAView further author information
Pages 1774-1777 | Received 16 Nov 2020, Accepted 18 Jan 2021, Published online: 09 Feb 2021

References

  • Döhner H, Estey E, Grimwade D, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129(4):424–447.
  • Walter RB, Estey EH. Management of older or unfit patients with acute myeloid leukemia. Leukemia. 2015;29(4):770–775.
  • Palmieri R, Paterno G, De Bellis E, et al. Therapeutic choice in older patients with acute myeloid leukemia: a matter of fitness. Cancers. 2020;12(1):120.
  • Walter RB, Estey EH. Selection of initial therapy for newly-diagnosed adult acute myeloid leukemia: limitations of predictive models. Blood Rev. 2020;(44):100679.
  • Petersdorf SH, Kopecky KJ, Slovak M, et al. A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia. Blood. 2013;121(24):4854–4860.
  • Garcia-Manero G, Othus M, Pagel JM, et al. SWOG S1203: a randomized phase III study of standard cytarabine plus daunorubicin (7 + 3) therapy versus idarubicin with high dose cytarabine (IA) with or without vorinostat (IA + V) in younger patients with previously untreated acute myeloid leukemia (AML) [abstract]. Blood. 2016;128(22):901–901.
  • Muller MP, Tomlinson G, Marrie TJ, et al. Can routine laboratory tests discriminate between severe acute respiratory syndrome and other causes of community-acquired pneumonia? Clin Infect Dis. 2005;40(8):1079–1086.
  • Ishihara R, Yamada T, Iishi H, et al. Quantitative analysis of the color change after iodine staining for diagnosing esophageal high-grade intraepithelial neoplasia and invasive cancer. Gastrointest Endosc. 2009;69(2):213–218.
  • Roelen CA, van Rhenen W, Groothoff JW, et al. The development and validation of two prediction models to identify employees at risk of high sickness absence. Eur J Public Health. 2013;23(1):128–133.
  • Pagel JM, Othus M, Garcia-Manero G, et al. Rapid donor identification improves survival in high-risk first-remission patients with acute myeloid leukemia. J Clin Oncol Oncol Pract. 2020;16(6):e464–e475.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.